Paradoxical effect of SARS‐CoV‐2 infection in patients with immune thrombocytopenia
Open Access
- 10 September 2020
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 192 (6) , 973-977
Abstract
Summary: Thrombocytopenia has been identified as a common complication of severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection in the general population. In an attempt to determine the impact of coronavirus disease 2019 (COVID‐19) in patients with immune thrombocytopenia (ITP), a retrospective single‐centre study was performed. Thrombocytosis was observed in patients with chronic ITP after SARS‐CoV‐2 infection, frequently needing treatment adjustment or even discontinuation of therapy. Relapses and newly diagnosed cases showed a fast response after initial treatment compared to ITP. Reduced immune activity due to lymphopenia during COVID‐19 could explain this paradoxical effect, although further studies are needed.Keywords
Funding Information
- FIS-Fondos Feder (PI19/00772)
This publication has 16 references indexed in Scilit:
- Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysisClinica Chimica Acta, 2020
- Thrombocytopenia and its association with mortality in patients with COVID‐19Journal of Thrombosis and Haemostasis, 2020
- Hematological findings and complications of COVID‐19American Journal of Hematology, 2020
- Early decrease in blood platelet count is associated with poor prognosis in COVID-19 patients—indications for predictive, preventive, and personalized medical approachEPMA Journal, 2020
- Association between platelet parameters and mortality in coronavirus disease 2019: Retrospective cohort studyPlatelets, 2020
- Mechanism of thrombocytopenia in COVID-19 patientsAnnals of Hematology, 2020
- Pediatric ITP: is it different from adult ITP?Hematology-American Society Hematology Education Program, 2018
- Emerging Concepts in Immune ThrombocytopeniaFrontiers in Immunology, 2018
- Thrombocytopenia in patients with severe acute respiratory syndrome (review)Hematology, 2005
- Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysisBMJ, 2003